The molecular and cellular biology CORE Facility will offer oligonucleotide synthesis and expression of polypeptides in vitro, plus consulting in cDNA or genomic library construction and screening. In addition, consultation for DNA sequencing services to investigators who are Program Grant participants at the University of Minnesota. The CORE is equipped with a Beckman Ultracentrifuge, Sorvall preparative centrifuges, Spectrophotometer, scintillation counter, and a polymerase chain reaction (PCR) machine, etc. In addition, the CORE is requesting a PCR-mate DNA synthesizer to support our synthetic oligonucleotide synthesis service. Oligonucleotides will be synthesized using phosphoramidite chemistry and fast oligodeprotecting methods (FOD), which allow for a one hour deprotection step versus the standard eight to twelve hour deprotection step. This will enable the CORE to provide a 24 hour turn around time on oligonucleotide synthesis requests. This synthesizer also will be used to synthesize oligonucleotide primers needed for sequencing analyses for the CORE Faculty and for synthesizing DNA templates for polypeptides of interest to be introduced into expression vectors for the purpose of producing reagents for studies on biological function or immunological recognition motifs. We justify the set-up CORE Facility since it is far more economical to synthesize oligonucleotides by ourselves and produce peptides of interest by recombinant methods as opposed to utilizing an outside vendor or direct peptide synthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA008131-05
Application #
6237951
Study Section
Project Start
1997-03-10
Project End
1998-02-28
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Kawai, Hideki; Raftery, Michael A (2010) Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor. J Biochem 147:743-9
Kawai, Hideki; Dunn, Susan M J; Raftery, Michael A (2008) Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor. Biochem Biophys Res Commun 366:834-9
Carter, Chris R J; Cao, Liren; Kawai, Hideki et al. (2007) Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Biochem Pharmacol 73:417-26
Conti-Fine, B M; Navaneetham, D; Lei, S et al. (2000) Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 393:279-94
Bollweg, G L; Sparber, S B (1999) Voltage associated with spontaneous embryonic motility in the developing chicken: an automated characterization during mid-late embryogenesis. Dev Psychobiol 34:5-19
Kawai, H; Carlson, B J; Okita, D K et al. (1999) Eserine and other tertiary amine interactions with Torpedo acetylcholine receptor postsynaptic membrane vesicles. Biochemistry 38:134-41
Wei, L N; Chang, L; HU, X (1999) Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities. Mol Cell Biochem 200:69-76
Schrott, L M; Sweeney, W A; Bodensteiner, K E et al. (1999) Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks. Pharmacol Biochem Behav 64:81-8
Macklin, K D; Maus, A D; Pereira, E F et al. (1998) Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287:435-9
Maus, A D; Pereira, E F; Karachunski, P I et al. (1998) Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 54:779-88

Showing the most recent 10 out of 50 publications